Cargando…
Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
Bromodomain 4 (BRD4) is an epigenetic regulator that, when inhibited, has anti-cancer effects. In this study, we investigated whether BRD4 could be a target for treatment of human hepatocellular carcinoma (HCC). We show that BRD4 is over-expressed in HCC tissues. Suppression of BRD4, either by siRNA...
Autores principales: | Li, Gong-Quan, Guo, Wen-Zhi, Zhang, Yi, Seng, Jing-Jing, Zhang, Hua-Peng, Ma, Xiu-Xian, Zhang, Gong, Li, Jie, Yan, Bing, Tang, Hong-Wei, Li, Shan-Shan, Wang, Li-Dong, Zhang, Shui-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823048/ https://www.ncbi.nlm.nih.gov/pubmed/26575167 http://dx.doi.org/10.18632/oncotarget.6275 |
Ejemplares similares
-
Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression
por: Guo, Yubin, et al.
Publicado: (2020) -
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
por: Pang, Yingxin, et al.
Publicado: (2022) -
Transcriptional regulation of BRD7 expression by Sp1 and c-Myc
por: Liu, Huaying, et al.
Publicado: (2008) -
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
por: Reynolds, Christine, et al.
Publicado: (2014) -
Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma
por: Chen, Chang-Long, et al.
Publicado: (2016)